Literature DB >> 9748303

The carboxyl terminus of Pneumocystis carinii glycoprotein A encodes a functional glycosylphosphatidylinositol signal sequence.

G Guadiz1, C G Haidaris, G N Maine, P J Simpson-Haidaris.   

Abstract

Pneumocystis carinii pneumonia is a hallmark disease associated with AIDS. An abundant glycoprotein, termed gpA, on the surface of P. carinii is considered an important factor in host-parasite interactions. The primary structure of ferret P. carinii gpA contains a carboxyl-terminal sequence characteristic of a signal for glycosylphosphatidylinositol (GPI) anchors. Here we report the capacity for this gpA carboxyl sequence to direct attachment of a secreted protein, human growth hormone (hGH), to the membranes of COS cells. A control fusion protein (hGHDAF37) was obtained which, under the direction of the GPI signal from decay accelerating factor, directs hGH cell surface expression. A construct (phGH2-1A30) was created similar to hGHDAF37 by fusing hGH to the putative GPI signal sequence encoded in the terminal 30 residues from a ferret P. carinii gpA cDNA clone. By indirect immunofluorescent staining, hGH was detected on the surface of COS cells transfected with phGH2-1A30; this surface location was confirmed by confocal laser cytometry. Metabolic labeling with [3H]ethanolamine and subsequent immunopurification of hGH from cells transfected with phGH2-1A30 confirmed that a lipid moiety characteristic of a conventional GPI anchor was linked covalently to hGH, and cell surface hGH2-1A30 fusion protein was sensitive to enzymatic cleavage by phosphatidylinositol-phospholipase C. Furthermore, hGH2-1A30 recombinant protein cofractionated with 5'-nucleotidase, a classical GPI-anchored membrane marker. Together, these results indicate that the carboxyl-terminal residues of ferret P. carinii gpA constitute a biologically functional GPI consensus domain, thus providing a potential mechanism for antigenic variation of P. carinii gpA during P. carinii pneumonia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9748303     DOI: 10.1074/jbc.273.40.26202

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Genetics of surface antigen expression in Pneumocystis carinii.

Authors:  J R Stringer; S P Keely
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

2.  Characterization of Pneumocystis carinii PHR1, a pH-regulated gene important for cell wall Integrity.

Authors:  T J Kottom; C F Thomas; A H Limper
Journal:  J Bacteriol       Date:  2001-12       Impact factor: 3.490

3.  Evidence for Proinflammatory β-1,6 Glucans in the Pneumocystis carinii Cell Wall.

Authors:  Theodore J Kottom; Deanne M Hebrink; Paige E Jenson; Gunnar Gudmundsson; Andrew H Limper
Journal:  Infect Immun       Date:  2015-04-27       Impact factor: 3.441

4.  Expression of Pneumocystis jirovecii major surface glycoprotein in Saccharomyces cerevisiae.

Authors:  Geetha Kutty; Katherine J England; Joseph A Kovacs
Journal:  J Infect Dis       Date:  2013-03-26       Impact factor: 5.226

5.  A novel glycosylphosphatidylinositol-anchored alkaline phosphatase dwells in the hepatic duct of the pearl oyster, Pinctada fucata.

Authors:  Li-Ping Xie; Yuan-Tai Wu; Yi-Ping Dai; Qing Li; Rong-Qing Zhang
Journal:  Mar Biotechnol (NY)       Date:  2007-07-13       Impact factor: 3.619

Review 6.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

7.  Gene Expression of Pneumocystis murina after Treatment with Anidulafungin Results in Strong Signals for Sexual Reproduction, Cell Wall Integrity, and Cell Cycle Arrest, Indicating a Requirement for Ascus Formation for Proliferation.

Authors:  Melanie T Cushion; Aleksey Porollo; Alan Ashbaugh; Keeley Hendrix; Michael J Linke; Nikeya Tisdale; Steven G Sayson
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.